The effect of ceruloplasmin on experimental infection with influenza virus APR 8/34 (H0N1) in the mouse.

Abstract	Ceruloplasmin administered in different variants confers on mice protection against experimental infection with influenza virus APR 8/34 (H0N1). The optimal variants are: inoculation of an extemporaneous virus-ceruloplasmin mixture, followed by two additional ceruloplasmin applications (which confers maximum protection against initial infection) and the administration of ceruloplasmin prior to virus inoculation (which assures the highest resistance to challenge infection).
Authors	I Samuel, E Tomas, A Istodor, F Bârnaure, N Cajal
Journal	Virologie (Virologie) 1980 Jul-Sep Vol. 31 Issue 3 Pg. 221-5 ISSN: 0253-181X [Print] Romania
PMID	7434566 (Publication Type: Journal Article)
Chemical References	Ceruloplasmin
Topics	Animals Ceruloplasmin (pharmacology, therapeutic use) Mice Orthomyxoviridae (drug effects, pathogenicity) Orthomyxoviridae Infections (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!